Market Highlights: The medical services area has seen floods of advancement over the recent many years driven by innovation, research, and improvement, and the presentation of recently created and innovative medical products. Intramedullary Nail modern surgical method of internal fracture fixation used in long bones such as the femur, tibia, and humerus intramedullary nail is a metal rod inserted into the medullary cavity of a bone and across the fracture in order to provide a solid support for the fractured bone. Intramedullary nailing is currently considered the gold standard for the treatment of femoral shaft fractures. Intramedullary fixation is valuable and appropriate for the majority of fractures. With newer nail designs and focus on technique, nailing can be extended to both proximal and distal extra-articular fractures. In addition, intramedullary nail fixation has emerged as the ‘gold standard’ treatment for femoral shaft fractures a factor that is anticipated to drive the global intramedullary nail market during the forecast period. The market study is being classified by Type (Long Gamma Nail (LGN), Trochanteric Femoral Nail (TFN) and Intertroch /Subtroch Nail (ITST)), by Application (Femoral Intramedullary Nail, Tibial Intramedullary Nail, Gamma intramedullary nail and Humerus bifurcate Intramedullary Na) and major geographies with country level break-up that includes South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
Key Players: The prominent players in the Intramedullary Nail are Zimmer Biomet (United States), Stryker Trauma(United States), Smith & Nephew (United Kingdom), Orthofix(United States), Aap Implantate (Germany), TREU Instrumente(Germany), CarboFix Orthopedics (United States), MIZUHO IKAKOGYO (Japan), Shandong Weigao Orthopedic Device Co., Ltd. (China) and PW MedTech (China).
In August 2019 The Orthopaedic Implant (OIC) launches its new product named Trochanteric Antegrade Femur Intramedullary Nail((TAFN). In addition to the TAFN, OIC's IM nail portfolio includes hip nails, a piriformis-entry antegrade and retrograde femur nail, and a tibial nail indicated for infra- and suprapatellar approaches
Key Questions Answered in the Report What will the Intramedullary Nail Market size and the growth rate be in Future? What are the key factors driving the Intramedullary Nail Market? What are the key market trends and macro-economic impacting the growth of the Intramedullary Nail Market? What are the challenges to market growth? Who are the key vendors in the Intramedullary Nail Market? What are the market opportunities and threats faced by the vendors in the Intramedullary Nail Market? Trending factors influencing the market shares of the Players. What are the key outcomes of the five forces analysis of the Intramedullary Nail Market?
Research Methodology: The top-down and bottom-up approaches are used to estimate and validate the size of the Global Intramedullary Nail market. In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Intramedullary Nail market. In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc. Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes New Entrants/Investors, Analysts and Strategic Business Planners, Intramedullary Nail Manufacturer, Intramedullary Nail Suppliers, Dealers, Suppliers, Traders, and Distributors, Venture Capitalists and Private Equity Firms, Government Regulatory and Research Organizations and End-Use Industry. This helps us to gather the data for the players revenue, operating cycle and expense, profit along with product or service growth etc. Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, Annual reports, press releases etc.